Patents by Inventor Daniela Bundschuh

Daniela Bundschuh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
    Publication number: 20080242681
    Abstract: Compounds of a certain formula 1 in which R1 and R2 have the meanings indicated in the description are novel kinase inhibitors. Formula (1), in which R1 is phenyl, phenyl substituted by R3 and/or R4, naphthalenyl, naphthalenyl substituted by and/or R6, aryl1, aryl1 substituted by R7 and/or R8, R9, R10 or R11, R2 is phenyl, phenyl substituted by R12 and/or R13, naphthalenyl, naphthalenyl substituted by R14 and/or R15, aryl2, aryl2 substituted by R16 and/or R17 or a radical selected from Formula (2).
    Type: Application
    Filed: January 19, 2005
    Publication date: October 2, 2008
    Applicant: Altana Pharma AG
    Inventors: Johannes Barsig, Monika Baudler, Daniela Bundschuh, Florian Gantner, Ulrich Graedler, Isabelle Heit, Thomas Martin, Michaela Schaefer, Imre Schlemminger, Josef Stadlwieser, Wolf-Ruediger Ulrich
  • Synergistic combination comprising roflumilast and (r,r) - formoterol
    Publication number: 20060199865
    Abstract: The invention relates to the combined administration of roflumilast and R,R-formoterol for the treatment of respiratory tract disorders.
    Type: Application
    Filed: November 26, 2003
    Publication date: September 7, 2006
    Inventors: Rolf Beume, Christian Weimar, Degenhard Marx, Daniela Bundschuh, Stefan-Lutz Wollin
  • Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
    Publication number: 20060189642
    Abstract: The invention relates to the administration of roflumilast oral or intravenously and an anticholinergic agent selected from the group of an ipratropium, oxitropium or tiotropium salt for the treatment of respiratory diseases.
    Type: Application
    Filed: March 26, 2004
    Publication date: August 24, 2006
    Applicant: ALTANA PHARMA AG
    Inventors: Daniela Bundschuh, Stefan-Lutz Wollin, Christian Weimar
  • Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
    Publication number: 20060147382
    Abstract: The invention relates to the administration of roflumilast and an anticholinergic agent selected from the group of an ipratropium, oxitropium or tiotropium salt for the treatment of respiratory diseases.
    Type: Application
    Filed: March 26, 2004
    Publication date: July 6, 2006
    Applicant: Altana Pharma AG
    Inventors: Daniela Bundschuh, Stefan-Lutz Wollin, Christian Weimar
  • Synergistic combination comprising roflumilast and formoterol
    Publication number: 20060142308
    Abstract: The invention relates to the combined administration of roflumilast and formoterol for the treatment of respiratory tract disorders.
    Type: Application
    Filed: November 26, 2003
    Publication date: June 29, 2006
    Applicant: Atlanta Pharma AG
    Inventors: Norbert Kolassa, Christian Weimar, Daniela Bundschuh, Rolf Beume, Degenhard Marx
  • Pharmaceutical composition of a pde4 or pde 3/4 inhibitor and histamine receptor antagonist
    Publication number: 20050112069
    Abstract: The invention relates to the combined administration of PDE4 or PDE3/4 inhibitors and histamine receptor antagonists for the treatment of respiratory diseases.
    Type: Application
    Filed: February 25, 2003
    Publication date: May 26, 2005
    Inventors: Rolf Beume, Daniela Bundschuh, Christian Weimar, Stefan-Lutz Wollin
  • Combination
    Publication number: 20050014762
    Abstract: The invention relates to the combined administration of PDE4 or PDE3/4 inhibitors and leukotriene receptor antagonists for the treatment of respiratory tract disorders.
    Type: Application
    Filed: September 17, 2002
    Publication date: January 20, 2005
    Inventors: Rolf Beume, Daniela Bundschuh, Christian Weimar, Stefan-Lutz Wollin
  • Tryptase inhibitors
    Patent number: 6613769
    Abstract: The invention relates to bifunctional tryptase inhibitors of formula (I) wherein H1 and H2 comprise a Q group and L is a linker of formula and the conformation of the H1, H2 and L groups is such that the groups are separated by a distance of from 20 to 45 Å. Pharmaceutical compositions and crystal forms of the compounds are described in addition to methods for producing and identifying such compounds, as well as the use of such compounds in methods of treating allergic and inflammatory diseases.
    Type: Grant
    Filed: January 22, 2001
    Date of Patent: September 2, 2003
    Assignees: Max-Planck-Gesellschaft zur Föderung der Wissenschaften. e.V., Altana Pharma AG
    Inventors: Wolfram Bode, Luis Moroder, Pedro Jose Barbosa Pereira, Andreas Bergner, Robert Huber, Christian Sommerhoff, Norbert Schaschke, Thomas Bär, Thomas Martin, Josef Stadlwieser, Wolf-Rüdiger Ulrich, Andreas Dominik, Ulrich Thibaut, Daniela Bundschuh, Rolf Beume, Karl-Josef Goebel
  • Tryptase inhibitors
    Patent number: 6489327
    Abstract: The invention relates to novel inhibitors of human tryptase which are used in the pharmaceutical industry for the production of medicaments.
    Type: Grant
    Filed: October 20, 2000
    Date of Patent: December 3, 2002
    Assignees: Max-Planck-Gesellschaft zur Fordrungder Wisenschaften, e.V., Byk Gulden Lomberg Chemische Fabrik GmbH
    Inventors: Thomas Bär, Thomas Martin, Josef Stadlwieser, Wolf-Rüdiger Ulrich, Andreas Dominik, Ulrich Thibaut, Daniela Bundschuh, Rolf Beume, Karl-Josef Goebel, Wolfram Bode, Luis Moroder, Pedro Jose Barbosa Pereira, Andreas Bergner, Robert Huber, Christian Sommerhoff, Norbert Schaschke